Looking at the universe of stocks we cover at Dividend Channel, on 2/6/18, Crestwood Equity Partners LP (CEQP - Get Report) will trade ex-dividend, for its quarterly dividend of $0.60, payable on 2/14/18. As a percentage of CEQP's recent stock price of $28.32, this dividend works out to approximately 2.12%, so look for shares of Crestwood Equity Partners LP to trade 2.12% lower — all else being equal — when CEQP shares open for trading on 2/6/18.Below is a dividend history chart for CEQP, showing historical dividends prior to the most recent $0.60 declared by Crestwood Equity Partners LP: In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CEQP is likely to continue, and whether the current estimated yield of 8.47% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of CEQP shares, versus its 200 day moving average: Looking at the chart above, CEQP's low point in its 52 week range is $20 per share, with $29.25 as the 52 week high point — that compares with a last trade of $28.12. According to the ETF Finder at ETF Channel, CEQP makes up 4.88% of the High Income Infrastructure MLP ETF ( YMLI) which is trading relatively unchanged on the day Friday. In Friday trading, Crestwood Equity Partners LP shares are currently down about 0.8% on the day.
More from Stocks
Home Depot, Kohl's, Boeing, Salesforce, Medicines Co. - 5 Things You Must Know
U.S. stocks look poised to post fresh record highs for a third consecutive session though concerns remain over a near-term trade pact between the U.S. and China; Home Depot and Kohl's report earnings; Boeing books $3.6 billion order for troubled 737 MAX jet.
Why Nordstrom Could Be a Clear Pick Ahead of Earnings
One analyst's data show trends that indicate the cheap retailing stock could see sales come in ahead of Wall Street's estimate.
Medicines Co. Surges After Cholesterol Drug Maker Linked to Novartis Takeover
Medicines Co. shares surged higher Tuesday following a report that suggested the cholesterol drug maker has attracted takeover interest from Swiss pharmaceutical giant Novartis AG NVS.
Dow Futures Rise, Global Stocks Gain Amid Mixed US-China Trade Talk Signals
Wall Street futures bounced higher again Tuesday, following a mixed session in Asia and solid gains across Europe, amid conflicting signals for a near-term U.S.-China trade agreement an ongoing political protests in Hong Kong.